Practical aspects of the control of cardiovascular risk in type 2 diabetes mellitus and the metabolic syndrome.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 2359598)

Published in Exp Clin Cardiol on January 01, 2007

Authors

Anca Cerghizan1, Cornelia Bala, Cristina Nita, Nicolae Hancu

Author Affiliations

1: Iuliu Hatieganu University of Medicine and Pharmacy; Clinical Center of Diabetes, Nutrition, Metabolic Diseases, Cluj-Napoca, Romania Correspondence: Dr Nicolae Hancu, Clinical Center of Diabetes, Nutrition, Metabolic Diseases, 2 Clinicilor St, 400 006 Cluj-Napoca, Romania. Telephone 40-264-594455, fax 40-264-599578, e-mail nhancu@umfcluj.ro.

Articles cited by this

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart (2005) 9.79

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) (2001) 8.45

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55

NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes (2003) 5.11

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care (1998) 4.49

The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord (2000) 3.83

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke (2002) 2.91

Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care (2005) 2.50

Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation (2004) 2.16

Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care (2002) 2.16

Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ (2002) 1.81

Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation (2004) 1.81

Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey. Diabetes Care (2005) 1.52

Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism? Heart (2005) 1.17

The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J (2006) 1.04

Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci (2005) 0.94

Risk factor clusters for metabolic syndrome in coronary heart disease: state of the science. Dimens Crit Care Nurs (2005) 0.80